Publication Date:
2008-08-02
Description:
The transition from naive to activated T cells is marked by alternative splicing of pre-mRNA encoding the transmembrane phosphatase CD45. Using a short hairpin RNA interference screen, we identified heterogeneous ribonucleoprotein L-like (hnRNPLL) as a critical inducible regulator of CD45 alternative splicing. HnRNPLL was up-regulated in stimulated T cells, bound CD45 transcripts, and was both necessary and sufficient for CD45 alternative splicing. Depletion or overexpression of hnRNPLL in B and T cell lines and primary T cells resulted in reciprocal alteration of CD45RA and RO expression. Exon array analysis suggested that hnRNPLL acts as a global regulator of alternative splicing in activated T cells. Induction of hnRNPLL during hematopoietic cell activation and differentiation may allow cells to rapidly shift their transcriptomes to favor proliferation and inhibit cell death.〈br /〉〈br /〉〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791692/" target="_blank"〉〈img src="https://static.pubmed.gov/portal/portal3rc.fcgi/4089621/img/3977009" border="0"〉〈/a〉 〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791692/" target="_blank"〉This paper as free author manuscript - peer-reviewed and accepted for publication〈/a〉〈br /〉〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Oberdoerffer, Shalini -- Moita, Luis Ferreira -- Neems, Daniel -- Freitas, Rui P -- Hacohen, Nir -- Rao, Anjana -- AI40127/AI/NIAID NIH HHS/ -- AI44432/AI/NIAID NIH HHS/ -- CA42471/CA/NCI NIH HHS/ -- R01 AI040127/AI/NIAID NIH HHS/ -- R01 AI040127-18/AI/NIAID NIH HHS/ -- R01 AI040127-19/AI/NIAID NIH HHS/ -- R01 AI044432/AI/NIAID NIH HHS/ -- R01 AI044432-09/AI/NIAID NIH HHS/ -- R01 AI044432-10/AI/NIAID NIH HHS/ -- R01 AI080875/AI/NIAID NIH HHS/ -- R01 AI080875-01/AI/NIAID NIH HHS/ -- R01 CA042471/CA/NCI NIH HHS/ -- R01 CA042471-23/CA/NCI NIH HHS/ -- R21 AI071060/AI/NIAID NIH HHS/ -- R21 AI071060-01/AI/NIAID NIH HHS/ -- R21 AI071060-02/AI/NIAID NIH HHS/ -- T32 HL066987/HL/NHLBI NIH HHS/ -- U19 AI070352/AI/NIAID NIH HHS/ -- New York, N.Y. -- Science. 2008 Aug 1;321(5889):686-91. doi: 10.1126/science.1157610. Epub 2008 Jul 10.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Pathology, Immune Disease Institute, Harvard Medical School, Boston, MA 02115, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/18669861" target="_blank"〉PubMed〈/a〉
Keywords:
*Alternative Splicing
;
Antigens, CD45/chemistry/*genetics
;
B-Lymphocytes/immunology/metabolism
;
CD4-Positive T-Lymphocytes/*immunology/*metabolism
;
Cell Line
;
Cell Line, Tumor
;
Heterogeneous-Nuclear Ribonucleoproteins/genetics/*metabolism
;
Humans
;
Lentivirus/genetics/physiology
;
*Lymphocyte Activation
;
Protein Isoforms/chemistry/genetics
;
RNA Interference
;
STAT5 Transcription Factor/genetics
;
T-Lymphocytes/*immunology/*metabolism
;
Tetradecanoylphorbol Acetate/pharmacology
;
Transcription, Genetic
;
Transduction, Genetic
;
Up-Regulation
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
